Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice.

Front Mol Neurosci · 2022 · PMC9179158 · PMID 35694440

Europe PMC DOI

hedged sentence

0.4800

closest p · 9.6× alpha

0.4800

boldest claim

The sentences

failed to reach statistical significancep = 0.48not close (p > 0.1)

This trend failed to reach statistical significance ( p = 0.48; Supplementary Figure 2G ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.